Prednisolone & Ibuprofen Interaction

Prednisolone (a corticosteroid) and ibuprofen (an NSAID) combined significantly increase the risk of gastrointestinal bleeding, peptic ulceration, and perforation. This is a well-documented major drug interaction. Both drugs independently compromise GI mucosal integrity through different mechanisms, and their combination is synergistically harmful. Concurrent use should generally be avoided, or if necessary, patients should receive GI protection.

Ibuprofen inhibits cyclooxygenase-1 (COX-1) and COX-2 enzymes, reducing prostaglandin synthesis. Prostaglandins normally protect the gastric mucosa by stimulating mucus and bicarbonate secretion and maintaining mucosal blood flow. Prednisolone inhibits phospholipase A2 (via annexin-1 induction), reducing arachidonic acid availability for both COX and lipoxygenase pathways. Additionally, corticosteroids impair mucosal healing and increase acid secretion. The combination depletes multiple layers of mucosal defense simultaneously.

Epidemiological studies have quantified the risk: NSAIDs alone carry approximately a 3-fold increased risk of serious GI events; corticosteroids alone carry approximately a 2-fold increase; the combination carries a 15-fold or greater increased risk. The FDA labels for both drug classes warn against concurrent use. Risk is highest in elderly patients, those with prior GI ulceration, and those also using anticoagulants.

Avoid concurrent use whenever possible. If both are clinically necessary, prescribe a proton pump inhibitor (e.g., omeprazole 20–40 mg daily) for GI protection. Use the lowest effective dose of each drug for the shortest duration. Consider acetaminophen (scheduled) as an NSAID alternative for pain. Assess and address other GI risk factors (H. pylori, alcohol use, anticoagulant therapy).

Stool color (melena) and symptoms of GI bleeding (abdominal pain, hematemesis). Hemoglobin/hematocrit if bleeding is suspected. Blood pressure and renal function (NSAIDs can impair both). Blood glucose (corticosteroids cause hyperglycemia). Electrolytes (corticosteroids cause sodium retention and potassium loss).

For pain management, acetaminophen up to 3g/day (4g for most adults) is preferred over ibuprofen in patients on corticosteroids. If NSAID is required, celecoxib (a selective COX-2 inhibitor) with a PPI has a lower GI bleeding risk. Topical NSAIDs may be appropriate for localized musculoskeletal pain.